Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy.
摘要：
The effect on forearm bone mineral content (BMC) of initiation and withdrawal of oestrogen/gestagen treatment was studied in a randomised trial in 94 healthy female volunteers six months to three years after the menopause. BMC was measured every three months for three years. BMC increased by 3·7% (p<0·001) during three years' hormone treatment and decreased by 5·7% (p<0·001) during three years' placebo treatment. The annual rate of bone loss after discontinuation of hormone therapy was identical with the bone loss in the placebo group. The present study indicates that even temporary hormone replacement therapy after the menopause will have a lasting beneficial effect on bone mass.
展开
关键词：
Double-Blind Studies Estrogens Menopause Age Factors Body Weight Studies Research Methodology Hormones Endocrine System Physiology
DOI：
10.1016/S0140-6736(81)91848-1
被引量：
年份：
1981
Taylor & Francis
Elsevier
万方医学
dx.doi.org
NCBI
查看更多
Europe PMC
NCBI
The Lancet
POPLINE
ResearchGate
ProQuest
EBSCO
geriatric.theclinics.com
cghjournal.org
obstetrics-gynaecology-journal.com
mysciencework.com
jacionline.org
press.endocrine.org
onlinecjc.ca
onacademic.com
fertstert.org
mendeley.com
www.socolar.com
通过文献互助平台发起求助，成功后即可免费获取论文全文。
相似文献
参考文献
引证文献
来源期刊
引用走势
辅助模式
引用
文献可以批量引用啦~
欢迎点我试用！
